March 18, 2014
Longitude Capital Maintains Momentum with Promotions and Team Expansion

February 27, 2014
Allergen Research Corporation Initiates Phase 2b Clinical Trial for Peanut Allergy Oral Immunotherapy

February 26, 2014
The Corus® CAD Gene Expression Test Can Help Commercial Health Plans Reduce Costs by Improving the Accuracy of the Diagnostic Workup in Patients with Suspected Obstructive Coronary Artery Disease

February 21, 2014
Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules

February 11, 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash

February 10, 2014
Jazz Pharmaceuticals Breaks Ground On New Manufacturing And Development Facility In Ireland

February 5, 2014
Report: Practice Fusion Nabs Top Spot as the Largest Cloud-Based EHR in the U.S.

February 3, 2014
The Corus® CAD Gene Expression Test Significantly Correlates With Plaque Burden and Obstructive Coronary Artery Disease as Validated by CT-Angiography

February 3, 2014
Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million

January 15, 2014
Collegium Pharmaceutical Announces Positive Topline Results of Human Abuse Potential Study Evaluating Intranasal Administration of Crushed Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Product

January 15, 2014
Practice Fusion Receives ONC-ACB Certification from the Drummond Group

Januray 13, 2014
Practice Fusion Partners with Healthagen’s Practice iQ to Help Physician Groups Perform as ACOs

January 13, 2014
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness

© 2008 Longitude Capital Management Co., LLC. All rights reserved.